RMS Medical Products Named to 2018 OTCQX Best 50
CHESTER, NY / ACCESSWIRE / January 26, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) is pleased to announce it has been named to the 2018 OTCQX® Best 50, a ranking of top performing companies traded on the OTCQX Best Market last year.
The OTCQX Best 50 is an annual ranking of the top 50 U.S. and international companies traded on the OTCQX market. The ranking is calculated based on an equal weighting of one-year total return and average daily dollar volume growth in the previous calendar year. Companies in the 2018 OTCQX Best 50 were ranked based on their performance in 2017.
"We are excited to be recognized in the OTCQX Best 50 list this year. This recognition finishes off a great year for RMS, where we had strong revenue growth, increased profitability, and we received clearance of our comprehensive FDA 510(k) for RMS' Freedom Integrated Infusion System," said Andy Sealfon, CEO of RMS. "I am looking forward to another great year at RMS."
For the complete 2018 OTCQX Best 50 ranking, visit http://bit.ly/OTCQX-best50-2018.
The OTCQX Best Market offers transparent and efficient trading of established, investor-focused U.S. and global companies. To qualify for the OTCQX market, companies must meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws and have a professional third-party sponsor introduction. The companies found on OTCQX are distinguished by the integrity of their operations and diligence with which they convey their qualifications.
About RMS Medical Products
The Company manufactures medical products used for infusions and suctioning. The Infusion product portfolio currently includes the FREEDOM60(R) and FreedomEdge™ Syringe Infusion Pumps, RMS Precision Flow Rate Tubing(TM) intended for both subcutaneous and intravenous medications, and RMS HIgH-Flo(TM) Subcutaneous Safety Needle Sets, which are well recognized by patients and clinicians for consistent flow rate performance, faster flow rates, and the assurance that each and every needle tip remains sharp and undamaged. These devices are used as an integrated system for infusions administered in professional healthcare settings as well as at home. The Company's RES-Q-VAC line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers.
The Company's website may be visited at www.rmsmedicalproducts.com.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "anticipated," "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports and registration statements filed with the Securities and Exchange Commission.
Princeton Research. Inc
SOURCE: Repro Med Systems, Inc.
Released January 26, 2018